Showing results (91-100 of 141) with videos related to
Sort By:
Pageof 15
American Heart Journal|January 1, 1982
Intracardiac electrophysiologic study of intravenous diltiazem and combined diltiazem-digoxin in patientsL B Mitchell, K R Jutzy, S J Lewis, et al.The American Journal of Cardiology|February 1, 1984
Clinical efficacy and electrophysiology of imipramine for ventricular tachycardiaS J Connolly, L B Mitchell, C D Swerdlow, et al.The American Journal of Cardiology|August 15, 1992
Comparison of atrial overdrive pacing with and without extrastimuli for termination of atrial flutterJ T Hii, L B Mitchell, H J Duff, et al.The Canadian Journal of Cardiology|June 1, 1992
Drug therapy of ventricular tachycardia: a cost comparison of randomized noninvasive and invasive approachesL B Mitchell, H J Duff, C E Miller, et al.Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|October 1, 1991
Mexiletine/quinidine combination therapy: electrophysiologic correlates of anti-arrhythmic efficacyH J Duff, L B Mitchell, D G Wyse, et al.Cytometry|April 20, 2001
Characterization of viable autofluorescent macrophages among cultured peripheral blood mononuclear cellsJ M Njoroge, L B Mitchell, M Centola, et al.Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|December 1, 1988
Procainamide in vivo modulates suppressor T lymphocyte activityB J Green, D G Wyse, H J Duff, et al.The American Journal of Cardiology|August 1, 1994
Prognostic significance of signal-averaged electrocardiogram after thrombolytic therapy and/or angioplasty during acute myocardial infarction (CAST substudy). Cardiac Arrhythmia Suppression Trial (CAST) SAECG Substudy InvestigatorsP Denes, N el-Sherif, R Katz, et al.American Heart Journal|June 30, 2001
Baseline factors predicting early resumption of driving after life-threatening arrhythmias in the Antiarrhythmics Versus Implantable Defibrillators (AVID) TrialK Hickey, A B Curtis, S Lancaster, et al.International Journal of Clinical Practice|January 23, 1999
Improved tolerability of felodipine compared with amlodipine in elderly hypertensives: a randomised, double-blind study in 535 patients, focusing on vasodilatory adverse events. The International Study GroupR M Schaefer, P M Aldons, E D Burgess, et al.Pageof 15